Heidendal G - Search Results

1

Visualization of cell death in vivo with the annexin A5 imaging protocol.

Reutelingsperger CP, Dumont E, Thimister PW, van Genderen H, Kenis H, van de Eijnde S, Heidendal G, Hofstra L. Reutelingsperger CP, et al. Among authors: heidendal g. J Immunol Methods. 2002 Jul 1;265(1-2):123-32. doi: 10.1016/s0022-1759(02)00075-3. J Immunol Methods. 2002. PMID: 12072183 Review.

2

Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5.

Boersma HH, Liem IH, Kemerink GJ, Thimister PW, Hofstra L, Stolk LM, van Heerde WL, Pakbiers MT, Janssen D, Beysens AJ, Reutelingsperger CP, Heidendal GA. Boersma HH, et al. Among authors: heidendal ga. Br J Radiol. 2003 Aug;76(908):553-60. doi: 10.1259/bjr/30385847. Br J Radiol. 2003. PMID: 12893698

3

The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.

Kietselaer BL, Hofstra L, Dumont EA, Reutelingsperger CP, Heidendal GA. Kietselaer BL, et al. Among authors: heidendal ga. Q J Nucl Med. 2003 Dec;47(4):349-61. Q J Nucl Med. 2003. PMID: 14973424 Free article. Review.

4

In vivo detection of cell death in the area at risk in acute myocardial infarction.

Thimister PW, Hofstra L, Liem IH, Boersma HH, Kemerink G, Reutelingsperger CP, Heidendal GA. Thimister PW, et al. Among authors: heidendal ga. J Nucl Med. 2003 Mar;44(3):391-6. J Nucl Med. 2003. PMID: 12621005 Free article.

5

Past, present, and future of annexin A5: from protein discovery to clinical applications.

Boersma HH, Kietselaer BL, Stolk LM, Bennaghmouch A, Hofstra L, Narula J, Heidendal GA, Reutelingsperger CP. Boersma HH, et al. Among authors: heidendal ga. J Nucl Med. 2005 Dec;46(12):2035-50. J Nucl Med. 2005. PMID: 16330568 Free article. Review.

6

Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure.

Kietselaer BL, Reutelingsperger CP, Boersma HH, Heidendal GA, Liem IH, Crijns HJ, Narula J, Hofstra L. Kietselaer BL, et al. Among authors: heidendal ga. J Nucl Med. 2007 Apr;48(4):562-7. doi: 10.2967/jnumed.106.039453. J Nucl Med. 2007. PMID: 17401092 Free article.

7

Bringing cell death alive.

Dumont EA, Reutelingsperger CP, Heidendal G, Hofstra L. Dumont EA, et al. Among authors: heidendal g. Cardiovasc Toxicol. 2003;3(3):207-18. doi: 10.1385/ct:3:3:207. Cardiovasc Toxicol. 2003. PMID: 14555787 Review.

8

Visualisation of cell death in vivo in patients with acute myocardial infarction.

Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, De Muinck E, Wellens HJ, Kemerink GJ, Reutelingsperger CP, Heidendal GA. Hofstra L, et al. Among authors: heidendal ga. Lancet. 2000 Jul 15;356(9225):209-12. doi: 10.1016/s0140-6736(00)02482-x. Lancet. 2000. PMID: 10963199

9

The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5.

Boersma HH, Stolk LM, Kenis H, Deckers NM, Vanderheyden JL, Hofstra L, Heidendal GA, Reutelingsperger CP. Boersma HH, et al. Among authors: heidendal ga. Anal Biochem. 2004 Apr 1;327(1):126-34. doi: 10.1016/j.ab.2004.01.004. Anal Biochem. 2004. PMID: 15033520

10

Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.

Kemerink GJ, Boersma HH, Thimister PW, Hofstra L, Liem IH, Pakbiers MT, Janssen D, Reutelingsperger CP, Heidendal GA. Kemerink GJ, et al. Among authors: heidendal ga. Eur J Nucl Med. 2001 Sep;28(9):1373-8. Eur J Nucl Med. 2001. PMID: 11585297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page